# FDA Inspection 980721 - Banco Vida Corp. - July 01, 2016

Source: https://www.keypedia.com/records/fda_inspections/banco-vida-corp/57359fd4-52a8-49d6-a83f-5e962b282136
Source feed: FDA_Inspections

> FDA Inspection 980721 for Banco Vida Corp. on July 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 980721
- Company Name: Banco Vida Corp.
- Inspection Date: 2016-07-01
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1149817 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/3fe6084f-3bce-4f63-b3dc-0f4b3fb38052)
- [FDA Inspection 1149817 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/511591a1-e5b6-4dde-84f8-6364eb6d3ac8)
- [FDA Inspection 1102161 - 2019-09-18](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/b7c6b6b6-81a9-45ca-93ab-50970e27ba52)
- [FDA Inspection 1102161 - 2019-09-18](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/b28debd3-afdc-4cf1-8ed2-aee9f866567f)
- [FDA Inspection 1036677 - 2017-12-07](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/d15bd0bd-6e23-45d9-b88e-eb4ed4a69793)

Company: https://www.keypedia.com/companies/banco-vida-corp/6710f827-76c1-4157-8a90-93c6458c3eca

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d